Stock Price
6.34
Daily Change
-0.29 -4.37%
Monthly
26.80%
Yearly
67.72%
Q1 Forecast
6.76

Silence Therapeutics reported $39K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Silence Therapeutics USD 39K 120K Mar/2026